US1005853A
(en)
|
1911-06-24 |
1911-10-17 |
Louis B Lewis |
Educational toy.
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
US3957965A
(en)
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
GB1257162A
(US07981874-20110719-C00313.png)
|
1968-02-16 |
1971-12-15 |
|
|
US4405598A
(en)
|
1976-01-30 |
1983-09-20 |
Fisons, Limited |
Composition for treating asthma
|
US4120285A
(en)
|
1976-11-01 |
1978-10-17 |
Owens-Illinois, Inc. |
Modular tubular solar energy collector apparatus
|
DE3104294A1
(de)
|
1981-02-07 |
1982-08-19 |
Hoechst Ag, 6000 Frankfurt |
Substituierte diazaspirodecane, ihre herstellung, ihre verwendung als stabilisatoren fuer organische polymere, sowie die so stabilisierten polymeren
|
US4429545A
(en)
|
1981-08-03 |
1984-02-07 |
Ocean & Atmospheric Science, Inc. |
Solar heating system
|
BE897058A
(fr)
|
1982-06-25 |
1983-12-16 |
Sandoz Sa |
Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
US5231170A
(en)
*
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
US4919915A
(en)
*
|
1987-03-03 |
1990-04-24 |
Paul Averback |
Method for detecting the ability to prevent red-to-green congophilic birefringence
|
DE69034007T2
(de)
|
1989-04-28 |
2003-05-08 |
Riker Laboratories Inc |
Inhalationsvorrichtung für Trockenpulver
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
DE4405387A1
(de)
|
1994-02-19 |
1995-08-24 |
Hoechst Ag |
Verfahren zur Herstellung von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
CA2174583A1
(en)
|
1995-05-05 |
1996-11-06 |
Alexander Chucholowski |
Sulfuric acid esters of sugar alcohols
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
BR9812693A
(pt)
|
1997-09-29 |
2000-08-22 |
Inhale Therapeutic Syst |
Uso de um agente bioativo, processo para formar uma microestrutura perfurada, microestrutura perfurada, processo para aumentar a dispersibilidade de um pó, pó de microestrutura perfurada, pó tendo dispersibilidade aumentada, sistema de inalação para a administração pulmonar de um agente bioativo a um paciente, e, processo para a liberação pulmonar de um ou mais agentes bioativos
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
KR100561223B1
(ko)
|
1998-06-12 |
2006-03-15 |
마이크로도스 테크놀로지즈 인코포레이티드 |
약제 및 약물의 계량, 포장 및 운송
|
US6197963B1
(en)
|
1998-08-13 |
2001-03-06 |
The Trustees Of The University Of Pennsylvania |
Non-peptide peptidomimetics
|
NZ511527A
(en)
*
|
1998-11-13 |
2002-10-25 |
Jago Res A |
Dry powder for inhalation
|
AU775914B2
(en)
|
1998-12-24 |
2004-08-19 |
Janssen Pharmaceutica N.V. |
Controlled release galantamine composition
|
JP2001151673A
(ja)
|
1999-09-06 |
2001-06-05 |
Nikken Chem Co Ltd |
吸入用粉末製剤の製造方法
|
US20020107173A1
(en)
*
|
1999-11-04 |
2002-08-08 |
Lawrence Friedhoff |
Method of treating amyloid beta precursor disorders
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
JP5025871B2
(ja)
|
2000-02-21 |
2012-09-12 |
エイチ.リュンドベック エイ/エス |
アミロイドの新規なダウン−レギュレート方法
|
US20080021085A1
(en)
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
AU2001257022B2
(en)
|
2000-04-13 |
2005-02-03 |
Mayo Foundation For Medical Education And Research |
Abeta 42 lowering agents
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
US20020016359A1
(en)
|
2000-06-29 |
2002-02-07 |
Hellberg Mark R. |
Compositions and methods of treating neurodegenerative diseases
|
US8519005B2
(en)
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
FR2815030A1
(fr)
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
US6511960B2
(en)
|
2001-01-05 |
2003-01-28 |
Alphamed Pharmaceuticals Corp |
Cromolyn for eye and ear infections
|
CA2444214A1
(en)
|
2001-04-23 |
2002-10-31 |
The Trustees Of The University Of Pennsylvania |
Amyloid plaque aggregation inhibitors and diagnostic imaging agents
|
EP1461031B1
(en)
|
2001-11-29 |
2016-06-29 |
Emisphere Technologies, Inc. |
Formulations for oral administration of cromolyn sodium
|
AU2003228963B2
(en)
|
2002-05-10 |
2009-01-22 |
Oriel Therapeutics, Inc. |
Dry powder inhalers
|
EP1601380A1
(en)
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
|
US8163734B2
(en)
|
2003-02-13 |
2012-04-24 |
Perttu J. Lindsberg |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
|
US20040223918A1
(en)
|
2003-05-07 |
2004-11-11 |
Chrysalis Technologies Incorporated |
Aerosolization of cromolyn sodium using a capillary aerosol generator
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
JP4471340B2
(ja)
|
2003-10-07 |
2010-06-02 |
芦森工業株式会社 |
バックル装置
|
CA2543482A1
(en)
*
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
GB0326632D0
(en)
*
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
WO2005063732A1
(en)
|
2003-12-23 |
2005-07-14 |
Microbia, Inc. |
Compounds and methods for the treatment of asthma
|
US20070093457A1
(en)
|
2004-02-11 |
2007-04-26 |
Nadir Arber |
Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
US20070293538A1
(en)
|
2004-04-13 |
2007-12-20 |
Myriad Genetics, Incorporated |
Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
|
ES2717248T3
(es)
|
2004-04-23 |
2019-06-20 |
Cydex Pharmaceuticals Inc |
Formulación de DPI que contiene sulfoalquil éter ciclodextrina
|
WO2006026555A2
(en)
|
2004-08-30 |
2006-03-09 |
Seo Hong Yoo |
Neuroprotective effect of solubilized udca in focal ischemic model
|
WO2006050165A2
(en)
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
ZA200708857B
(en)
|
2005-04-22 |
2009-01-28 |
Genentech Inc |
Method for treating dementia or alzheimer's disease with a CD30 antibody
|
EP1893576A4
(en)
|
2005-05-27 |
2010-03-17 |
Univ Kingston |
TREATMENT OF PROTEIN DISORDERING
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
AR059356A1
(es)
|
2006-02-14 |
2008-03-26 |
Astrazeneca Ab |
Nuevos radioligandos
|
US7700618B2
(en)
|
2006-03-06 |
2010-04-20 |
Pfizer Inc |
Sulfonyl benzimidazole derivatives
|
JP2009529502A
(ja)
|
2006-03-09 |
2009-08-20 |
ワラタ ファーマシューティカルズ, インコーポレイテッド |
タンパク質凝集の障害の処置のためのシクロヘキサン多価アルコール処方物
|
EP2023919A4
(en)
|
2006-05-08 |
2010-12-22 |
Molecular Neuroimaging Llc |
COMPOUNDS AND AMYLOID PROBES FOR THERAPY AND IMAGING USES
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
US20100173960A1
(en)
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
JP2010510254A
(ja)
|
2006-11-24 |
2010-04-02 |
ワラタ ファーマシューティカルズ, インコーポレイテッド |
アルツハイマー病および関連の神経変性疾患のための併用処置
|
ES2468551T3
(es)
|
2007-04-18 |
2014-06-16 |
Probiodrug Ag |
Derivados de nitrovinil-diamina como inhibidores de la glutaminil ciclasa
|
MX2009011127A
(es)
|
2007-04-18 |
2010-03-10 |
Janssen Alzheimer Immunotherap |
Metodo de prevencion y tratamiento de angiopatia amiloide cerebral.
|
US7858803B2
(en)
|
2007-04-27 |
2010-12-28 |
The General Hospital Corporation |
Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
|
WO2009011782A2
(en)
|
2007-07-13 |
2009-01-22 |
Abbott Biotechnology Ltd. |
METHODS AND COMPOSITIONS FOR PULMONARY ADMINISTRATION OF A TNFa INHIBITOR
|
GB0714134D0
(en)
|
2007-07-19 |
2007-08-29 |
Norton Healthcare Ltd |
Dry-powder medicament
|
SI2182983T1
(sl)
|
2007-07-27 |
2014-09-30 |
Janssen Alzheimer Immunotherapy |
Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
US8450466B2
(en)
|
2008-03-21 |
2013-05-28 |
The General Hosptial Corporation |
Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
|
KR20110071050A
(ko)
|
2008-04-29 |
2011-06-28 |
파넥스트 |
알츠하이머 질환 및 관련 장애의 치료를 위한 조니사미드 및 아캄프로세이트의 조합 조성물
|
JP5816883B2
(ja)
*
|
2009-01-22 |
2015-11-18 |
ラクオリア創薬株式会社 |
Cb2受容体作動活性を有するn−置換飽和ヘテロ環スルホン化合物
|
US8381454B1
(en)
|
2009-01-23 |
2013-02-26 |
Markus R. Robinson |
Segmented, elongated, expandable, 4-season, double-walled, low-cost, rigid extruded plastic panel structures
|
CA2751125C
(en)
|
2009-01-29 |
2017-06-20 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
JP5836807B2
(ja)
|
2009-03-05 |
2015-12-24 |
アッヴィ・インコーポレイテッド |
Il−17結合タンパク質
|
WO2010104973A1
(en)
|
2009-03-11 |
2010-09-16 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
|
AU2010225923B2
(en)
*
|
2009-03-16 |
2016-10-27 |
Ipintl, Llc |
Treating Alzheimer's disease and osteoporosis and reducing aging
|
EP2248517B1
(en)
|
2009-05-08 |
2014-03-26 |
PARI Pharma GmbH |
Concentrated mast cell stabilizing pharmaceutical formulations
|
JP2013501046A
(ja)
|
2009-08-06 |
2013-01-10 |
ニューラルタス ファーマシューティカルズ, インコーポレイテッド |
マクロファージ関連障害の処置
|
US20120175082A1
(en)
|
2009-09-14 |
2012-07-12 |
Kmetovicz Ronald E |
Solar heat pipe heat exchanger
|
SI3378856T1
(sl)
|
2009-09-24 |
2021-03-31 |
Wista Laboratories Ltd. |
Kristalinični metiltioninijevi klorid hidrati
|
EP2322163A1
(en)
|
2009-11-03 |
2011-05-18 |
Pharnext |
New therapeutics approaches for treating alzheimer disease
|
US20110262442A1
(en)
|
2009-11-06 |
2011-10-27 |
Adenios, Inc. |
Compositions for treating cns disorders
|
JP5854476B2
(ja)
|
2009-11-30 |
2016-02-09 |
アデア ファーマスーティカルズ,インコーポレイテッド |
圧縮性コーティングで被覆された医薬組成物及び錠剤並びに製造方法
|
US8455755B2
(en)
|
2009-12-07 |
2013-06-04 |
Electrotherm |
Concentrated photovoltaic and thermal solar energy collector
|
EP2377860A1
(en)
|
2010-04-16 |
2011-10-19 |
AC Immune S.A. |
Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
|
WO2011136754A1
(en)
|
2010-04-26 |
2011-11-03 |
Mahmut Bilgic |
A medicament developed for the treatment of respiratory diseases
|
TR201901644T4
(tr)
*
|
2010-09-30 |
2019-02-21 |
Chiesi Farm Spa |
İnhalasyon için kuru toz formülasyonlarında magnesyum stearat. kullanımı.
|
US20120121656A1
(en)
|
2010-11-15 |
2012-05-17 |
Revalesio Corporation |
Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
|
WO2012107706A1
(en)
|
2011-02-11 |
2012-08-16 |
Wista Laboratories Ltd. |
Phenothiazine diaminium salts and their use
|
KR20150011807A
(ko)
*
|
2012-05-25 |
2015-02-02 |
질리어, 인크. |
자일리톨계 항-점액성 조성물과 관련 방법 및 조성물
|
JP5907396B2
(ja)
|
2012-10-23 |
2016-04-26 |
国立大学法人福井大学 |
腫瘍融解症候群の治療薬及び予防薬
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
CN104869993B
(zh)
|
2012-10-25 |
2019-01-15 |
通用医疗公司 |
治疗阿尔茨海默病及相关疾病的组合疗法
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
CA2913235C
(en)
*
|
2013-05-23 |
2021-07-13 |
Aztherapies, Inc. |
Methods for delivering cromolyn
|
AU2014340182B2
(en)
|
2013-10-22 |
2019-05-23 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
PT3104853T
(pt)
|
2014-02-10 |
2020-01-14 |
Respivant Sciences Gmbh |
Tratamento com estabilizadores de mastócitos para distúrbios sistémicos
|
ES2792682T3
(es)
|
2014-02-10 |
2020-11-11 |
Respivant Sciences Gmbh |
Métodos para el tratamiento de enfermedades pulmonares con estabilizadores de mastocitos
|
WO2016081466A1
(en)
|
2014-11-21 |
2016-05-26 |
Biohaven Pharmaceutical Holding Company Ltd. |
Sublingual administration of riluzole
|
US11723864B2
(en)
|
2015-05-29 |
2023-08-15 |
The Texas A&M University System |
Antimicrobial and anti-inflammatory compositions
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
US20180311236A1
(en)
|
2015-10-28 |
2018-11-01 |
Ab Science |
Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease
|
CN108472393A
(zh)
|
2015-11-19 |
2018-08-31 |
阿尔茨治疗方法公司 |
用于治疗阿尔茨海默病和有关病症的方法
|
JP2018538273A
(ja)
|
2015-11-23 |
2018-12-27 |
エーゼットセラピーズ, インコーポレイテッド |
虚血性脳卒中を処置するための組成物および方法
|
JP7250312B2
(ja)
|
2016-03-25 |
2023-04-03 |
エービー サイエンス |
筋萎縮性側索硬化症患者の下位集団の治療のためのマシチニブの使用
|
CN116889562A
(zh)
|
2016-08-31 |
2023-10-17 |
通用医疗公司 |
与神经退行性疾病相关的神经炎症中的巨噬细胞/小胶质细胞
|
CN111565711B
(zh)
|
2017-07-20 |
2023-01-03 |
阿茨治疗股份有限公司 |
色甘酸钠和布洛芬的粉末化制剂
|
JP2021521122A
(ja)
|
2018-04-09 |
2021-08-26 |
ザ ジェネラル ホスピタル コーポレイション |
筋萎縮性側索硬化症および関連障害の治療のための併用療法
|
KR20210071943A
(ko)
|
2018-07-02 |
2021-06-16 |
더 제너럴 하스피탈 코포레이션 |
크로몰린 소듐 및 α-락토스의 분말화된 제형
|
AU2019336698A1
(en)
|
2018-09-05 |
2021-03-25 |
Aztherapies, Inc. |
Methods of treating cytokine release syndrome
|
US20220062222A1
(en)
|
2018-12-10 |
2022-03-03 |
The General Hospital Corporation |
Cromolyn esters and uses thereof
|
IL297023A
(en)
|
2020-04-06 |
2022-12-01 |
Massachusetts Gen Hospital |
Methods for treating inflammatory conditions caused by the corona virus
|
US20230226017A1
(en)
|
2020-06-04 |
2023-07-20 |
The General Hospital Corporation |
Methods of treating a coronavirus infection
|